Christo Kole

1.1k total citations · 1 hit paper
17 papers, 668 citations indexed

About

Christo Kole is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christo Kole has authored 17 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Christo Kole's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Retinal Development and Disorders (3 papers). Christo Kole is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Retinal Development and Disorders (3 papers). Christo Kole collaborates with scholars based in Greece, United States and France. Christo Kole's co-authors include Dimitriοs Schizas, Nikolaos Charalampakis, Michalis V. Karamouzis, Amanda Psyrri, Dimitrios C. Ziogas, Evangelos Koustas, Panagiota Economopoulou, Stylianos Kykalos, Michail Vailas and Dimitrios Moris and has published in prestigious journals such as PLoS ONE, Antioxidants and Redox Signaling and Investigative Ophthalmology & Visual Science.

In The Last Decade

Christo Kole

16 papers receiving 662 citations

Hit Papers

Immunotherapy for pancreatic cancer: A 2020 update 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunotherapy for pancreatic cancer: A 2020 update
    2020 308 citations Dimitriοs Schizas, Nikolaos Charalampakis et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christo Kole Greece 11 319 277 153 112 107 17 668
Man Liu China 14 287 0.9× 375 1.4× 181 1.2× 143 1.3× 89 0.8× 43 825
Emin Avşar United States 11 379 1.2× 302 1.1× 116 0.8× 80 0.7× 144 1.3× 18 637
Eva Løbner Lund Denmark 15 235 0.7× 408 1.5× 72 0.5× 212 1.9× 91 0.9× 45 753
Daniëlle Raats Netherlands 15 325 1.0× 391 1.4× 158 1.0× 154 1.4× 113 1.1× 28 818
Yunuo Mao China 10 198 0.6× 538 1.9× 102 0.7× 168 1.5× 55 0.5× 13 826
Hiroyuki Arai Japan 13 244 0.8× 270 1.0× 74 0.5× 81 0.7× 136 1.3× 71 734
Guangzhi Wang China 18 160 0.5× 490 1.8× 155 1.0× 314 2.8× 103 1.0× 49 909
Elsa Vanhecke France 7 224 0.7× 281 1.0× 64 0.4× 92 0.8× 87 0.8× 8 620
Guoqing Wu China 12 226 0.7× 240 0.9× 254 1.7× 198 1.8× 42 0.4× 24 702
Monica Aasrum Norway 16 260 0.8× 241 0.9× 84 0.5× 96 0.9× 27 0.3× 25 521

Countries citing papers authored by Christo Kole

Since Specialization
Citations

This map shows the geographic impact of Christo Kole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christo Kole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christo Kole more than expected).

Fields of papers citing papers by Christo Kole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christo Kole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christo Kole. The network helps show where Christo Kole may publish in the future.

Co-authorship network of co-authors of Christo Kole

This figure shows the co-authorship network connecting the top 25 collaborators of Christo Kole. A scholar is included among the top collaborators of Christo Kole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christo Kole. Christo Kole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Kole, Christo, et al.. (2024). Biomarkers in cardiorenal syndrome, a potential use in precision medicine. Journal of Nephrology. 37(8). 2127–2138. 3 indexed citations
3.
Kole, Christo, et al.. (2023). Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review. Cardiovascular Drugs and Therapy. 38(5). 1017–1032. 14 indexed citations
4.
Kole, Christo, et al.. (2023). Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review. Current Treatment Options in Neurology. 25(4). 71–92. 9 indexed citations
5.
Kole, Christo, Nikolaos Charalampakis, Stratigoula Sakellariou, et al.. (2022). Hereditary Diffuse Gastric Cancer: A 2022 Update. Journal of Personalized Medicine. 12(12). 2032–2032. 6 indexed citations
6.
Bennett, Samuel, et al.. (2022). Advances in stem cell therapy in Alzheimer’s disease: a comprehensive clinical trial review. PubMed. 9. 2–2. 22 indexed citations
7.
Kole, Christo, Nikolaos Charalampakis, George Papaxoinis, et al.. (2021). Immunotherapy for Gastric Cancer: A 2021 Update. Immunotherapy. 14(1). 41–64. 34 indexed citations
8.
Kole, Christo, Nikolaos Charalampakis, Michail Vailas, et al.. (2021). Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update. Cancer Immunology Immunotherapy. 71(4). 761–768. 10 indexed citations
9.
Charalampakis, Nikolaos, Georgios Papageorgiou, Christo Kole, et al.. (2021). Immunotherapy for Cholangiocarcinoma: a 2021 Update. Immunotherapy. 13(13). 1113–1134. 16 indexed citations
10.
Kole, Christo, Nikolaos Charalampakis, Michail Vailas, et al.. (2020). Immunotherapy for Hepatocellular Carcinoma: A 2021 Update. Cancers. 12(10). 2859–2859. 97 indexed citations
11.
Mead, Ben, et al.. (2020). Viral delivery of multiple miRNAs promotes retinal ganglion cell survival and functional preservation after optic nerve crush injury. Experimental Eye Research. 197. 108071–108071. 19 indexed citations
12.
Mastoraki, Aikaterini, Dimitriοs Schizas, Nikolaos Charalampakis, et al.. (2020). Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma. Molecular Diagnosis & Therapy. 24(5). 557–569. 6 indexed citations
13.
Schizas, Dimitriοs, Nikolaos Charalampakis, Christo Kole, et al.. (2020). Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treatment Reviews. 86. 102016–102016. 308 indexed citations breakdown →
14.
Kole, Christo, Benedikt Brommer, Naoki Nakaya, et al.. (2020). Activating Transcription Factor 3 (ATF3) Protects Retinal Ganglion Cells and Promotes Functional Preservation After Optic Nerve Crush. Investigative Ophthalmology & Visual Science. 61(2). 31–31. 44 indexed citations
15.
Schizas, Dimitriοs, Nikolaos Charalampakis, Christo Kole, et al.. (2020). Immunotherapy for Esophageal Cancer: A 2019 Update. Immunotherapy. 12(3). 203–218. 29 indexed citations
16.
Kole, Christo, Corinne Da Silva, Géraldine Millet-Puel, et al.. (2016). Identification of an Alternative Splicing Product of the Otx2 Gene Expressed in the Neural Retina and Retinal Pigmented Epithelial Cells. PLoS ONE. 11(3). e0150758–e0150758. 9 indexed citations
17.
Xin, Mei, Antoine Chaffiol, Christo Kole, et al.. (2016). The Thioredoxin Encoded by the Rod-Derived Cone Viability Factor Gene Protects Cone Photoreceptors Against Oxidative Stress. Antioxidants and Redox Signaling. 24(16). 909–923. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Man Liu Breakdown of academic impact, for papers by Emin Avşar Breakdown of academic impact, for papers by Eva Løbner Lund Breakdown of academic impact, for papers by Daniëlle Raats Breakdown of academic impact, for papers by Yunuo Mao Breakdown of academic impact, for papers by Hiroyuki Arai Breakdown of academic impact, for papers by Guangzhi Wang Breakdown of academic impact, for papers by Elsa Vanhecke Breakdown of academic impact, for papers by Guoqing Wu Breakdown of academic impact, for papers by Monica Aasrum
Rankless by CCL
2026